In addition, it is unknown whether bone resorption-derived (Ca2+)e might have been responsible for activating the Ca2+ channels, pumps and exchangers to promote differentiation and growth of metastatic lung cancer cells (MLCCs) in bone. This evidence concerns the gene CA2 and lung cancer.